EcoDrugPlus

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPNYG00000000109
Gene Symbol: CYSLTR1
3 Cross references
172 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSPNYG00000008101
Gene Symbol: CDA
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSPNYG00000018696
Gene Symbol: LOC102213897
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSPNYG00000023616
Gene Symbol: LOC102197004
2 Cross references
520 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSPNYG00000023706
Gene Symbol: LOC102196352
2 Cross references
517 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSPNYG00000020658
Gene Symbol: LOC102197914
3 Cross references
474 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSPNYG00000022150
Gene Symbol: LOC102213061
2 Cross references
518 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSPNYG00000020813
Gene Symbol: LOC102198204
3 Cross references
539 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSPNYG00000023620
Gene Symbol: LOC102196446
2 Cross references
518 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSPNYG00000020037
Gene Symbol: CYP19A1
4 Cross references
244 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSPNYG00000005325
Gene Symbol: LOC102212274
3 Cross references
179 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSPNYG00000016272
Gene Symbol: LOC102211892
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).